Drugmakers point to US expansion plans amid Trump’s 100% drug tariff
The 100% rate on imported, branded pharma products will not apply to drugmakers constructing manufacturing facilities in the US.
Business & Regulation
Trump tasks FDA to crack down on misleading drug advertising
Novo Nordisk slashes 11% of workforce as Eli Lilly pressure tightens
Bavarian Nordic boosts 2025 guidance as takeover offer looms
CSL slashes 15% of workforce and offshoots vaccine division
Eli Lilly accused of bribing providers to prescribe GLP-1RA drugs
Podcast: US tariff news and Q2 earnings influence pharma trends
Mounjaro and Zepbound fuel strong Q2 growth for Eli Lilly
